Pioglitazone attenuates atrial remodeling and vulnerability to atrial fibrillation in alloxan-induced diabetic rabbits. (Q48194292)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28665544%20AND%20SRC:MED&resulttype=core&format=json

24 March 2020

title

Pioglitazone attenuates atrial remodeling and vulnerability to atrial fibrillation in alloxan-induced diabetic rabbits (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28665544%20AND%20SRC:MED&resulttype=core&format=json

24 March 2020

0 references

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28665544%20AND%20SRC:MED&resulttype=core&format=json

24 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28665544%20AND%20SRC:MED&resulttype=core&format=json

24 March 2020

Guangping Li

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28665544%20AND%20SRC:MED&resulttype=core&format=json

Panagiotis Korantzopoulos

24 March 2020

object named as

Panagiotis Korantzopoulos

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28665544%20AND%20SRC:MED&resulttype=core&format=json

24 March 2020

Ruimeng Liu

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28665544%20AND%20SRC:MED&resulttype=core&format=json

24 March 2020

Huaying Fu

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28665544%20AND%20SRC:MED&resulttype=core&format=json

24 March 2020

Jian Li

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28665544%20AND%20SRC:MED&resulttype=core&format=json

24 March 2020

Xinghua Wang

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28665544%20AND%20SRC:MED&resulttype=core&format=json

24 March 2020

Lijun Cheng

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28665544%20AND%20SRC:MED&resulttype=core&format=json

24 March 2020

Tong Liu

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28665544%20AND%20SRC:MED&resulttype=core&format=json

24 March 2020

publication date

1 October 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28665544%20AND%20SRC:MED&resulttype=core&format=json

Cardiovascular Therapeutics

24 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28665544%20AND%20SRC:MED&resulttype=core&format=json

24 March 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28665544%20AND%20SRC:MED&resulttype=core&format=json

24 March 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28665544%20AND%20SRC:MED&resulttype=core&format=json

The role of oxidative stress in the pathogenesis and perpetuation of atrial fibrillation

24 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12284

Diabetes mellitus and atrial remodeling: mechanisms and potential upstream therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12284

Diabetes mellitus and atrial fibrillation: Pathophysiological mechanisms and potential upstream therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12284

Pioglitazone attenuates inflammatory atrial fibrosis and vulnerability to atrial fibrillation induced by pressure overload in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12284

Beneficial effects of pioglitazone on atrial structural and electrical remodeling in vitro cellular models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12284

Meta-analysis of cohort and case-control studies of type 2 diabetes mellitus and risk of atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12284

Metabolic syndrome and risk of development of atrial fibrillation: the Niigata preventive medicine study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12284

Independent contribution of diabetes to increased prevalence and incidence of atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12284

Diabetes mellitus, glycemic control, and risk of atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12284

AGEs-RAGE system mediates atrial structural remodeling in the diabetic rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12284

Statin use and development of atrial fibrillation: a systematic review and meta-analysis of randomized clinical trials and observational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12284

Statins and prevention of atrial fibrillation in patients with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12284

Enalapril, irbesartan, and angiotensin-(1-7) prevent atrial tachycardia-induced ionic remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12284

Prevention of atrial fibrillation with omega-3 fatty acids: a meta-analysis of randomised clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12284

Oral vitamin C administration reduces early recurrence rates after electrical cardioversion of persistent atrial fibrillation and attenuates associated inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12284

Antioxidant vitamins in the prevention of atrial fibrillation: what is the evidence?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12284

Probucol and succinobucol in atrial fibrillation: pros and cons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12284

Antioxidant interventions as novel preventive strategies for postoperative atrial fibrillation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12284

Modification of oxidative stress by pioglitazone in the heart of alloxan-induced diabetic rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12284

Rosiglitazone, an agonist of peroxisome proliferator-activated receptor gamma, protects against gastric ischemia-reperfusion damage in rats: role of oxygen free radicals generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12284

Meta-analysis of the effect of thiazolidinediones on serum C-reactive protein levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12284

Peroxisome proliferator-activated receptor-alpha (PPARalpha): at the crossroads of obesity, diabetes and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12284

Pleiotropic effects of thiazolidinediones: taking a look beyond antidiabetic activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12284

Peroxisome proliferator-activated receptor-alpha and receptor-gamma activators prevent cardiac fibrosis in mineralocorticoid-dependent hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12284

Pioglitazone, a peroxisome proliferator-activated receptor-gamma agonist, attenuates left ventricular remodeling and failure after experimental myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12284

Effects of pioglitazone on hyperglycemia-induced alterations in antioxidative system in tissues of alloxan-treated diabetic animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12284

Chronic rapid atrial pacing. Structural, functional, and electrophysiological characteristics of a new model of sustained atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12284

Molecular mechanisms underlying ionic remodeling in a dog model of atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12284

CCN2 protein is an announcing marker for cardiac remodeling following STZ-induced moderate hyperglycemia in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12284

Effects of angiotensin II type 1 receptor antagonist on electrical and structural remodeling in atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12284

Pioglitazone, a peroxisome proliferator-activated receptor-gamma activator, attenuates atrial fibrosis and atrial fibrillation promotion in rabbits with congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12284

Antifibrotic Effects of Pioglitazone at Low Doses on the Diabetic Rat Kidney Are Associated with the Improvement of Markers of Cell Turnover, Tubular and Endothelial Integrity, and Angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12284

21 January 2018

Identifiers

DOI

10.1111/1755-5922.12284

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28665544%20AND%20SRC:MED&resulttype=core&format=json

24 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28665544%20AND%20SRC:MED&resulttype=core&format=json